The economical challenge in the treatment of chronic heart failure: is primary prophylactic ICD therapy cost-effective in Europe?


Despite great scepticism and opposition in the early years of implantable cadioverter/defibrillator (ICD) therapy, 25 years of clinical practice and multiple randomized multicentre studies have proven that ICD therapy is highly effective to prevent sudden cardiac death. In patients with or without symptomatic heart failure and impaired left ventricular… (More)
DOI: 10.1093/europace/eup140